Arteris (AIP) stock is drawing attention after the company said Li Auto is using its FlexNoC IP and Magillem software in the new L9 Livis SUV to handle AI compute and integration automation.

The Li Auto deployment and recent first quarter update have landed during a period of very strong momentum, with a 30 day share price return of 49.48% and a year to date share price return of 132.86%, while the 1 year total shareholder return sits at a very large 408.84% and the 3 year total shareholder return is 4.37x.

If you are interested in how AI related stories like Arteris fit into a broader opportunity set, it could be worth reviewing 34 AI small caps.

With Arteris now trading near its analyst target of US$37.75 after a sharp run, the key question is whether recent Li Auto wins and revenue progress still leave upside on the table or if the market is already pricing in future growth.

Most Popular Narrative: 77% Overvalued

The most followed valuation narrative puts Arteris fair value at $20.50, well below the last close at $36.28, which sets up a wide expectations gap.

The analysts have a consensus price target of $20.5 for Arteris based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $24.0, and the most bearish reporting a price target of just $16.0.

Want to see what justifies that gap between today’s price and the $20.50 fair value line? The narrative leans on brisk revenue expansion, improved margins and a rich future earnings multiple. The key pieces are all quantified and stitched together into one coherent valuation story.

Result: Fair Value of $20.50 (OVERVALUED)

However, there is still the risk that Arteris stays loss making for longer than expected or that large customers scale back deals, which could challenge this upbeat narrative.

Next Steps

Given the mix of excitement and caution in this story, it makes sense to look at the numbers yourself and decide where you stand. You can start with the 1 key reward and 2 important warning signs.

Looking for more investment ideas?

If this Arteris story has your attention, do not stop here. The right watchlist of fresh opportunities can be just as important as any single stock.

• Broaden your opportunity set by scanning 49 high quality undervalued stocks that combine quality fundamentals with prices that may sit below many investors' radars.
• Prioritise resilience by reviewing the 66 resilient stocks with low risk scores that our model flags for steadier risk profiles across different conditions.
• Add potential future watchlist candidates by checking the screener containing 21 high quality undiscovered gems that could complement or diversify away from your current holdings.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.